{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:22:55Z","timestamp":1782202975503,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071628386","type":"print"},{"value":"9781071628393","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2839-3_20","type":"book-chapter","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T14:07:02Z","timestamp":1668089222000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Viral Gene Delivery in Chondrocytes"],"prefix":"10.1007","author":[{"given":"Christopher V.","family":"Nagelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo E.","family":"De La Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","unstructured":"Evans CH, Ghivizzani SC, Smith P et al (2000) Using gene therapy to protect and restore cartilage. Clin Orthop Relat Res (379 Suppl):S214\u2013S219. https:\/\/doi.org\/10.1097\/00003086-200010001-00027","DOI":"10.1097\/00003086-200010001-00027"},{"key":"20_CR2","doi-asserted-by":"publisher","unstructured":"Kantor A, McClements ME, MacLaren RE (2020) CRISPR-Cas9 DNA base-editing and prime-editing. Int J Mol Sci 21(17). https:\/\/doi.org\/10.3390\/ijms21176240","DOI":"10.3390\/ijms21176240"},{"key":"20_CR3","doi-asserted-by":"publisher","unstructured":"Lundstrom K (2018) Viral vectors in gene therapy. Diseases 6(2). https:\/\/doi.org\/10.3390\/diseases6020042","DOI":"10.3390\/diseases6020042"},{"issue":"10","key":"20_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1302\/2046-3758.810.BJR-2019-0265","volume":"8","author":"CH Evans","year":"2019","unstructured":"Evans CH (2019) The vicissitudes of gene therapy. Bone Joint Res 8(10):469\u2013471. https:\/\/doi.org\/10.1302\/2046-3758.810.BJR-2019-0265","journal-title":"Bone Joint Res"},{"key":"20_CR5","doi-asserted-by":"crossref","unstructured":"Evans CH, Ghivizzani SC, Robbin PD (2021) Orthopaedic gene therapy: 25 years on. J Bone Joint Surg 9(8):e20.00220","DOI":"10.2106\/JBJS.RVW.20.00220"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coviro.2021.03.006","volume":"48","author":"UF Greber","year":"2021","unstructured":"Greber UF, Gomez-Gonzalez A (2021) Adenovirus \u2013 a blueprint for gene delivery. Curr Opin Virol 48:49\u201356. https:\/\/doi.org\/10.1016\/j.coviro.2021.03.006","journal-title":"Curr Opin Virol"},{"issue":"10","key":"20_CR7","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","volume":"91","author":"Y Yang","year":"1994","unstructured":"Yang Y, Nunes FA, Berencsi K et al (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 91(10):4407\u20134411. https:\/\/doi.org\/10.1073\/pnas.91.10.4407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR8","doi-asserted-by":"publisher","unstructured":"Ricobaraza A, Gonzalez-Aparicio M, Mora-Jimenez L et al (2020) High-capacity adenoviral vectors: expanding the scope of gene therapy. Int J Mol Sci 21(10). https:\/\/doi.org\/10.3390\/ijms21103643","DOI":"10.3390\/ijms21103643"},{"issue":"18","key":"20_CR9","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/sj.gt.3302060","volume":"10","author":"T Ito","year":"2003","unstructured":"Ito T, Tokunaga K, Maruyama H et al (2003) Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing. Gene Ther 10(18):1623\u20131628. https:\/\/doi.org\/10.1038\/sj.gt.3302060","journal-title":"Gene Ther"},{"issue":"2","key":"20_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/104303401750061186","volume":"12","author":"BD Brower-Toland","year":"2001","unstructured":"Brower-Toland BD, Saxer RA, Goodrich LR et al (2001) Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. Hum Gene Ther 12(2):117\u2013129. https:\/\/doi.org\/10.1089\/104303401750061186","journal-title":"Hum Gene Ther"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1385\/1-59259-345-3:235","volume":"215","author":"GD Palmer","year":"2003","unstructured":"Palmer GD, Gouze E, Gouze JN et al (2003) Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol Biol 215:235\u2013246. https:\/\/doi.org\/10.1385\/1-59259-345-3:235","journal-title":"Methods Mol Biol"},{"issue":"4","key":"20_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/jor.1100180411","volume":"18","author":"FD Shuler","year":"2000","unstructured":"Shuler FD, Georgescu HI, Niyibizi C et al (2000) Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 18(4):585\u2013592. https:\/\/doi.org\/10.1002\/jor.1100180411","journal-title":"J Orthop Res"},{"issue":"5","key":"20_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M","volume":"43","author":"P Smith","year":"2000","unstructured":"Smith P, Shuler FD, Georgescu HI et al (2000) Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 43(5):1156\u20131164. https:\/\/doi.org\/10.1002\/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M","journal-title":"Arthritis Rheum"},{"issue":"2","key":"20_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00441-006-0371-5","volume":"328","author":"A Oberholzer","year":"2007","unstructured":"Oberholzer A, John T, Kohl B et al (2007) Adenoviral transduction is more efficient in alginate-derived chondrocytes than in monolayer chondrocytes. Cell Tissue Res 328(2):383\u2013390. https:\/\/doi.org\/10.1007\/s00441-006-0371-5","journal-title":"Cell Tissue Res"},{"issue":"2","key":"20_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/humc.2017.142","volume":"29","author":"RS Watson Levings","year":"2018","unstructured":"Watson Levings RS, Broome TA, Smith AD et al (2018) Gene therapy for osteoarthritis: pharmacokinetics of intra-articular self-complementary adeno-associated virus interleukin-1 receptor antagonist delivery in an equine model. Hum Gene Ther Clin Dev 29(2):90\u2013100. https:\/\/doi.org\/10.1089\/humc.2017.142","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"11","key":"20_CR16","doi-asserted-by":"publisher","first-page":"9468","DOI":"10.1128\/JVI.73.11.9468-9477.1999","volume":"73","author":"J Yang","year":"1999","unstructured":"Yang J, Zhou W, Zhang Y et al (1999) Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J Virol 73(11):9468\u20139477. https:\/\/doi.org\/10.1128\/JVI.73.11.9468-9477.1999","journal-title":"J Virol"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","volume":"24","author":"L Lisowski","year":"2015","unstructured":"Lisowski L, Tay SS, Alexander IE (2015) Adeno-associated virus serotypes for gene therapeutics. Curr Opin Pharmacol 24:59\u201367. https:\/\/doi.org\/10.1016\/j.coph.2015.07.006","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"20_CR18","doi-asserted-by":"publisher","first-page":"e0243359","DOI":"10.1371\/journal.pone.0243359","volume":"15","author":"Q Chen","year":"2020","unstructured":"Chen Q, Luo H, Zhou C et al (2020) Comparative intra-articular gene transfer of seven adeno-associated virus serotypes reveals that AAV2 mediates the most efficient transduction to mouse arthritic chondrocytes. PLoS One 15(12):e0243359. https:\/\/doi.org\/10.1371\/journal.pone.0243359","journal-title":"PLoS One"},{"issue":"12","key":"20_CR19","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1089\/hum.2009.030","volume":"20","author":"LR Goodrich","year":"2009","unstructured":"Goodrich LR, Choi VW, Carbone BA et al (2009) Ex vivo serotype-specific transduction of equine joint tissue by self-complementary adeno-associated viral vectors. Hum Gene Ther 20(12):1697\u20131702. https:\/\/doi.org\/10.1089\/hum.2009.030","journal-title":"Hum Gene Ther"},{"issue":"10","key":"20_CR20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty DM (2008) Self-complementary AAV vectors; advances and applications. Mol Ther 16(10):1648\u20131656. https:\/\/doi.org\/10.1038\/mt.2008.171","journal-title":"Mol Ther"},{"issue":"2","key":"20_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/s1046-2023(02)00219-0","volume":"28","author":"D Grimm","year":"2002","unstructured":"Grimm D (2002) Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods 28(2):146\u2013157. https:\/\/doi.org\/10.1016\/s1046-2023(02)00219-0","journal-title":"Methods"},{"key":"20_CR22","doi-asserted-by":"publisher","unstructured":"Srivastava A, Mallela KMG, Deorkar N et al (2021) Manufacturing challenges and rational formulation development for AAV viral vectors. J Pharm Sci. https:\/\/doi.org\/10.1016\/j.xphs.2021.03.024","DOI":"10.1016\/j.xphs.2021.03.024"},{"issue":"2","key":"20_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s1063-4584(97)80007-6","volume":"5","author":"R Kang","year":"1997","unstructured":"Kang R, Marui T, Ghivizzani SC et al (1997) Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthr Cartil 5(2):139\u2013143. https:\/\/doi.org\/10.1016\/s1063-4584(97)80007-6","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"20_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/v3060677","volume":"3","author":"T Maetzig","year":"2011","unstructured":"Maetzig T, Galla M, Baum C et al (2011) Gammaretroviral vectors: biology, technology and application. Viruses 3(6):677\u2013713. https:\/\/doi.org\/10.3390\/v3060677","journal-title":"Viruses"},{"issue":"7","key":"20_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone MC, O\u2019Doherty U (2018) Clinical use of lentiviral vectors. Leukemia 32(7):1529\u20131541. https:\/\/doi.org\/10.1038\/s41375-018-0106-0","journal-title":"Leukemia"},{"issue":"11","key":"20_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1089\/hum.2005.16.1287","volume":"16","author":"CM Fouletier-Dilling","year":"2005","unstructured":"Fouletier-Dilling CM, Bosch P, Davis AR et al (2005) Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. Hum Gene Ther 16(11):1287\u20131297. https:\/\/doi.org\/10.1089\/hum.2005.16.1287","journal-title":"Hum Gene Ther"},{"issue":"5","key":"20_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/sj.gt.3303092","volume":"15","author":"GD Palmer","year":"2008","unstructured":"Palmer GD, Stoddart MJ, Gouze E et al (2008) A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors. Gene Ther 15(5):357\u2013363. https:\/\/doi.org\/10.1038\/sj.gt.3303092","journal-title":"Gene Ther"},{"issue":"5","key":"20_CR28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11095-011-0629-9","volume":"29","author":"C Sapet","year":"2012","unstructured":"Sapet C, Pellegrino C, Laurent N et al (2012) Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo. Pharm Res 29(5):1203\u20131218. https:\/\/doi.org\/10.1007\/s11095-011-0629-9","journal-title":"Pharm Res"},{"issue":"4","key":"20_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/ar311","volume":"3","author":"MA Del Vecchio","year":"2001","unstructured":"Del Vecchio MA, Georgescu HI, McCormack JE et al (2001) Approaches to enhancing the retroviral transduction of human synoviocytes. Arthritis Res 3(4):259\u2013263. https:\/\/doi.org\/10.1186\/ar311","journal-title":"Arthritis Res"}],"container-title":["Methods in Molecular Biology","Cartilage Tissue Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2839-3_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T14:07:56Z","timestamp":1668089276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2839-3_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"ISBN":["9781071628386","9781071628393"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2839-3_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"11 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}